| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 09/25/2001 | US6294568 Antiinflammatory agents and antitumor agents containing the compounds as the active ingredients and cox2 enzyme inhibitors |
| 09/25/2001 | US6294560 Synthesis of clasto-lactacystin β-lactone and analogs thereof |
| 09/25/2001 | US6294558 Antiinflammatory agents and prostaglantins |
| 09/25/2001 | US6294557 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject. |
| 09/25/2001 | US6294551 N-linked sulfonamides of heterocyclic thioesters |
| 09/25/2001 | US6294542 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 09/25/2001 | CA2213404C Use of angiogenesis suppressors for inhibiting hair growth |
| 09/20/2001 | WO2001068673A1 Oligonucleotide analogues, methods of synthesis and methods of use |
| 09/20/2001 | WO2001068645A2 N-cyanomethylcarboxamides and their use as protease inhibitors |
| 09/20/2001 | WO2001068619A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | WO2001068602A1 A new oligomer compound and a use thereof |
| 09/20/2001 | WO2001068601A1 Process for the production of 2-hydroxyethylmaleimide and the product obtained by the process |
| 09/20/2001 | WO2001068600A2 Benzylated pde4 inhibitors |
| 09/20/2001 | WO2001068586A2 α4β1 AND α4β7 INTEGRIN INHIBITORS |
| 09/20/2001 | WO2001068033A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001017961A3 Intermediates for the production of naphthyridine-3-carboxylic acid derivatives |
| 09/20/2001 | US20010023240 Compounds and compositions for delivering active agents |
| 09/20/2001 | DE10013599A1 Verfahren zur Racemisierung von N-Acylaminosäuren mittels Übergangsmetallkatalysatoren A process for the racemisation of N-acylamino acids by means of transition metal catalysts |
| 09/20/2001 | CA2403017A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | CA2402384A1 Benzylated pde4 inhibitors |
| 09/20/2001 | CA2402319A1 Oligonucleotide analogues, methods of synthesis and methods of use |
| 09/19/2001 | EP1133229A1 Fungicides containing pyrrolidones as their active agents |
| 09/19/2001 | EP0675712B1 Reduction of hair growth employing sulfhydryl reactive compounds |
| 09/19/2001 | CN1313855A Inhibitors of alpha4Betal mediated cell adhesion alpha Beta |
| 09/19/2001 | CN1071322C Process for producing 5,6-dihydro-1,3-oxazines |
| 09/19/2001 | CN1071319C Intermediate for synthesis of pesticide |
| 09/18/2001 | US6291527 Hydrosoluble salts obtained through a reaction between ketoprofen and glucosamine and/or proline and/or hydroxyproline; useful for antiinflammatory and analgesic treatment of joints and mucous membranes. |
| 09/18/2001 | US6291510 Small molecule inhibitors of rotamase enzyme activity |
| 09/18/2001 | US6291509 Synergistic immunosuppressant composition containing a 2,2'-bi-1H-pyrrole compound |
| 09/18/2001 | US6291478 Compounds of the benzylaminodiacetamide family, compositions comprising them, preparation process and uses |
| 09/18/2001 | US6291453 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/18/2001 | US6291417 Cleaning process |
| 09/18/2001 | US6291413 O-substituted N,N-diacylhydroxylamine bleach activators and compositions employing the same |
| 09/18/2001 | US6291400 Herbicidal compounds |
| 09/18/2001 | US6289892 Partial liquid breathing of fluorocarbons |
| 09/13/2001 | WO2001066547A1 Process for producing carbapenem derivatives |
| 09/13/2001 | WO2001066534A2 Cyclic and bicyclic diamino histamine-3 receptor antagonists |
| 09/13/2001 | WO2001066521A1 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 09/13/2001 | WO2001066071A1 Oxidation dyeing composition for keratinous fibres and dyeing method using same |
| 09/13/2001 | WO2001009169A3 Cysteine protease inhibitors |
| 09/13/2001 | WO2000059883A3 Method for producing n-aryl-aza-heterocycles in the presence of cesium carbonate |
| 09/13/2001 | WO2000052012A3 A method for synthesizing porphyrin compounds |
| 09/13/2001 | CA2373097A1 Oxidation dyeing composition for keratinous fibres and dyeing method using same |
| 09/12/2001 | EP1132379A1 Novel thiol derivatives, process for producing the same and utilization thereof |
| 09/12/2001 | EP1132370A2 Process for producing n-substituted polyhydroxy nitrogen-containing heterocyles |
| 09/12/2001 | EP1132086A2 Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure |
| 09/12/2001 | EP1132085A1 Drugs and reagents containing n-acyloxylated cycloalkyl compounds as the active ingredient |
| 09/12/2001 | EP1131288A1 Pyrrolidine derivatives-ccr-3 receptor antagonists |
| 09/12/2001 | EP1131064A2 Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus |
| 09/12/2001 | EP1131060A2 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor |
| 09/12/2001 | EP0915845B1 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 09/12/2001 | EP0888317B1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 09/12/2001 | CN1070857C Process for producing 1-aminopynolidine |
| 09/12/2001 | CN1070845C Benzamidoxime derivative, process for production thereof, and agrotoricultural bactericide |
| 09/12/2001 | CN1070831C Stabilized monomer composition |
| 09/11/2001 | US6288241 Crystalline polymorphic form of 1-methyl-5-p-toluoylpyrrple-2-acetamidoacetic acid guaiacyl ester (MED 15) |
| 09/11/2001 | US6288240 Preparation of 2-hydroxy-5-oxoproline and analogs thereof |
| 09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
| 09/11/2001 | US6288231 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 09/11/2001 | US6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 09/11/2001 | US6288086 N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/11/2001 | US6288055 Analgesic agents |
| 09/11/2001 | US6288036 Bradykinin type peptides |
| 09/07/2001 | WO2001064646A2 Hydrazones and analogs as cholesterol lowering agents |
| 09/07/2001 | WO2001064637A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 09/07/2001 | WO2001064636A1 Crystalline forms of antibiotic side chain intermediates |
| 09/07/2001 | WO2001064635A1 Ningalin b analogs employable for reversing multidrug resistance |
| 09/07/2001 | WO2001010383A3 Caspase inhibitors and uses thereof |
| 09/07/2001 | CA2401673A1 Ningalin b analogs employable for reversing multidrug resistance |
| 09/07/2001 | CA2401643A1 Crystalline forms of antibiotic side chain intermediates |
| 09/06/2001 | US20010020024 Opioid analgesics |
| 09/06/2001 | US20010020021 Metalloprotease inhibitor |
| 09/06/2001 | DE10007704A1 New hydrazine and pyrrolidine compounds bonded to a solid phase useful as linker and scavenger groups for carbonyl compounds, especially in combinatorial chemistry |
| 09/05/2001 | EP1130017A2 Azole derivatives and their use as superoxide radical inhibitors |
| 09/05/2001 | EP1129071A1 Phenyl-substituted cyclic enaminones |
| 09/05/2001 | EP1129070A1 Neurotrophic diamide and carbamate agents |
| 09/05/2001 | EP0726269B1 Quinolinecarboxylic acid derivatives and salts thereof |
| 09/05/2001 | EP0699185B1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS |
| 09/05/2001 | EP0681572B1 Thiazolidinethione-activated polyalkylene oxides |
| 09/05/2001 | CN1311793A Antipicornaviral compounds, their prepn. and use |
| 09/05/2001 | CN1311774A trifuoro methylpyrrol carboxamides |
| 09/05/2001 | CN1311771A Benzamidine derivative |
| 09/05/2001 | CN1311767A Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 09/05/2001 | CN1311677A Remedies or preventives for intractable epilepsy |
| 09/04/2001 | USH1992 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their pharmaceutical uses |
| 09/04/2001 | US6284892 Method for producing salts of cyclic amidines |
| 09/04/2001 | US6284788 Use of known agonists of the central cannabinoid receptor CB1 |
| 09/04/2001 | US6284785 1-arenesulfonyl-2-aryl-pyrrolidine and pyridine derivatives |
| 09/04/2001 | US6284784 2-hydroxymethyl derivatives |
| 09/04/2001 | US6284767 Retroviral protease inhibiting compounds |
| 09/04/2001 | CA2224062C Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
| 08/30/2001 | WO2001062757A1 Novel compounds |
| 08/30/2001 | WO2001062735A1 Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 08/30/2001 | WO2001062729A1 Novel compounds |
| 08/30/2001 | WO2001062728A1 Novel compounds |
| 08/30/2001 | WO2001062727A1 Novel process for preparing 4-substituted-1h-pyrrole-3-carboxylic acid ester |
| 08/30/2001 | WO2001062726A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/30/2001 | WO2001062704A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062246A1 Method for treating neurodegeneration |
| 08/30/2001 | WO2001062245A2 Bilirubin or biliverdin degradation fragments |